重药控股：10月27日召开董事会会议

Group 1 - The core point of the article is that Chongqing Pharmaceutical Holdings (SZ 000950) announced a board meeting to discuss the transfer of a 20% stake in Chongqing Huayi Holdings Financial Co., Ltd. and related transactions [1] - For the first half of 2025, the revenue composition of Chongqing Pharmaceutical Holdings was as follows: 94.81% from pharmaceutical wholesale, 4.73% from pharmaceutical retail, and 0.46% from other businesses [1] - As of the report date, the market capitalization of Chongqing Pharmaceutical Holdings was 9.2 billion yuan [1]